Sumitomo Mitsui Trust Group’s Maravai LifeSciences MRVI Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,091	Closed	-$544K	–	1191
2021 Q3	$544K	Sell	11,091 -7,331	-40%	-$358K	﹤0.01%	1095
2021 Q2	$769K	Hold	18,422	–	–	﹤0.01%	1073
2021 Q1	$657K	Hold	18,422	–	–	﹤0.01%	1059
2020 Q4	$517K	Buy	+18,422	New	+$513K	﹤0.01%	1065

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MRVI Position: Q4 2021 in Review

Sumitomo Mitsui Trust Group sold out of Maravai LifeSciences (MRVI) in Q4 2021, closing a stake of 11,091 shares — an estimated $544K sold.

Sumitomo Mitsui Trust Group first reported a position in MRVI in Q4 2020 and held it in 4 quarters. The position peaked at $769K in Q2 2021. 229 funds tracked by Wall St. Rank hold MRVI as of Q4 2021.

Sumitomo Mitsui Trust Group reported no remaining Maravai LifeSciences position as of Q4 2021 after selling out during the quarter.
Sumitomo Mitsui Trust Group sold 11,091 Maravai LifeSciences shares in Q4 2021, an estimated $544K.
Sumitomo Mitsui Trust Group first reported a position in Maravai LifeSciences in Q4 2020 and held it in 4 quarters.
Sumitomo Mitsui Trust Group's Maravai LifeSciences position peaked at $769K in Q2 2021.
229 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2021, filed 2 Feb 2022.